PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31100859-2 2019 The glycosaminoglycan heparin, widely used as a clinical anticoagulant, has previously been shown to inhibit the Alzheimer"s disease-relevant beta-secretase 1 (BACE1). Heparin 22-29 beta-secretase 1 Homo sapiens 160-165 17004727-0 2006 Heparin derivatives as inhibitors of BACE-1, the Alzheimer"s beta-secretase, with reduced activity against factor Xa and other proteases. Heparin 0-7 beta-secretase 1 Homo sapiens 37-43 27474542-0 2016 Low anticoagulant heparin oligosaccharides as inhibitors of BACE-1, the Alzheimer"s beta-secretase. Heparin 18-25 beta-secretase 1 Homo sapiens 60-66 18322389-4 2008 METHODS: We tested a number of selectively desulphated and chemically modified heparins for their ability to inhibit BACE1 and other proteases in vitro using APP fluorescent resonance energy transfer peptide substrates RESULTS: Several lead compounds have been identified that are effective beta-secretase inhibitors, but have negligible activity as anticoagulants or as inhibitors of other aspartyl proteases structurally related to beta-secretase. Heparin 79-87 beta-secretase 1 Homo sapiens 117-122 14530380-3 2003 We show that HS and heparin interact directly with BACE1 and inhibit in vitro processing of peptide and APP substrates. Heparin 20-27 beta-secretase 1 Homo sapiens 51-56 16716081-0 2006 Heparin activates beta-secretase (BACE1) of Alzheimer"s disease and increases autocatalysis of the enzyme. Heparin 0-7 beta-secretase 1 Homo sapiens 34-39 16716081-5 2006 However, heparin has also been reported to directly inhibit BACE1 activity in vitro. Heparin 9-16 beta-secretase 1 Homo sapiens 60-65 16716081-6 2006 To clarify the role of heparin in regulating BACE1, we examined the effect of heparin on the activity of recombinant human BACE1 (rBACE1) in vitro. Heparin 78-85 beta-secretase 1 Homo sapiens 123-128 16716081-9 2006 Heparin affinity chromatography demonstrated that heparin interacted strongly with the zymogen form of rBACE1 and bound to a peptide homologous to the N-terminal pro sequence of BACE1. Heparin 0-7 beta-secretase 1 Homo sapiens 104-109 16716081-9 2006 Heparin affinity chromatography demonstrated that heparin interacted strongly with the zymogen form of rBACE1 and bound to a peptide homologous to the N-terminal pro sequence of BACE1. Heparin 50-57 beta-secretase 1 Homo sapiens 104-109 16716081-12 2006 Our results strongly suggest that heparin stimulates the partially active BACE1 zymogen, and we propose that the activation is mediated by high-affinity binding of heparin to the pro domain. Heparin 34-41 beta-secretase 1 Homo sapiens 74-79 16716081-12 2006 Our results strongly suggest that heparin stimulates the partially active BACE1 zymogen, and we propose that the activation is mediated by high-affinity binding of heparin to the pro domain. Heparin 164-171 beta-secretase 1 Homo sapiens 74-79